KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...

WE haven’t hit spring yet, but hayfever sufferers can brace for a high pollen count in the coming weeks. The usual symptoms – ...

Objective: To investigate the effect of Mometasone furoate (Elocon Cream) Nasal Spray (MFNS) treatment on hearing secretory Otitis Media (SOM) in younger children. Methods: Seventy-six children with ...

MIAMI BEACH, Fla. — Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according to a speaker at Masters of Pediatric Dermatology.

Watch this brave woman share her ongoing journey with the skin condition Topical Steroid Withdrawal. Josie North, a card game designer, from Shropshire, UK, first experienced signs of Topical ...

van Halewijn KF et al. Effectiveness of potent topical corticosteroids versus mild ones in primary care for children with moderate flare-ups of atopic dermatitis; results of a randomised controlled ...

“Antihistamines and nasal steroids in combination can decrease some of the reactivity of both the nasal and tonsil tissues in the back of the throat, which can decrease mucus production and help ...

Figuring out how to stop post-nasal drip quickly can help mitigate the other uncomfortable symptoms of the phenomenon, like sore throat or stomach upset. While post-nasal drip is typically a mild ...

Steroids for COPD include oral steroids, inhaled steroids, and combination inhalers. Each type comes with its own benefits and side effects. While no cure currently exists for COPD, several types ...

Surgical intervention may be considered in patients with refractory symptoms with objective evidence of disease by endoscopy and/or CT. Surgery does not represent a cure to CRS but rather ...

Exposure to irritants has been shown to increase nasal symptoms and cause exacerbations ... scale (VAS): VAS less than 3 (mild: intranasal corticosteroids); VAS above 3–10 (moderate to severe ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.